低反应者冻胚与鲜胚移植对比:一项系统综述
该系统综述纳入1项随机对照试验和14项非随机研究,评估低反应者全胚冷冻后冻胚移植与鲜胚移植的生殖结局。高质量随机对照试验证据显示冻胚移植降低活产率、临床妊娠率和累积活产率,非随机研究证据极不确定。在满足POSEIDON标准的女性中,鲜胚移植与更低流产率相关。
要点
- 低反应者冻胚移植的活产率、临床妊娠率和累积活产率均低于鲜胚移植。
- 满足POSEIDON标准者鲜胚移植流产率更低(RR 1.31,95%CI 1.11-1.56)。
- 全胚冷冻策略在低反应者中未显示优于鲜胚移植的生殖结局。
核心结论
- 在低反应者中,全胚冷冻后冻胚移植与鲜胚移植相比未产生更好的生殖结局,鲜胚移植可能改善结局。
研究设计与样本
- 去重后筛选4423篇文章的标题和摘要,评估154篇全文,最终纳入1项随机对照试验和14项非随机研究。
- 提取主要结局活产率和次要结局数据,方案注册于PROSPERO(CRD420251138047)。
主要发现
- 1项随机对照试验的高确定性证据显示,冻胚移植降低活产率(RR 0.79,95%CI 0.65-0.94)、临床妊娠率(RR 0.83,95%CI 0.71-0.97)和累积活产率(RR 0.86,95%CI 0.75-0.99)。
- 非随机研究提供极不确定证据,显示两组活产率无显著差异(RR 1.00,95%CI 0.65-1.55)。
- 在满足POSEIDON标准的女性中,鲜胚移植与更低流产率相关(RR 1.31,95%CI 1.11-1.56)。
- 一致证据表明冻胚移植在其他生殖结局方面未产生显著改善。
关键数值与推荐
- 主要结局活产率:随机对照试验RR 0.79(95%CI 0.65-0.94),非随机研究RR 1.00(95%CI 0.65-1.55)。
- 临床妊娠率:随机对照试验RR 0.83(95%CI 0.71-0.97)。
- 累积活产率:随机对照试验RR 0.86(95%CI 0.75-0.99)。
- POSEIDON标准女性流产率:RR 1.31(95%CI 1.11-1.56)。
临床怎么用
- 低反应者行辅助生殖时,不宜常规采用全胚冷冻后冻胚移植策略。
- 可考虑鲜胚移植以改善生殖结局,尤其对满足POSEIDON标准的低反应者。
- 临床决策需结合个体情况,并与患者充分讨论冻胚移植的潜在劣势。
局限性
- 仅1项随机对照试验,其余14项为非随机研究,证据确定性有限。
- 非随机研究提供的证据极不确定,结果需谨慎解读。
- 作者建议进一步开展随机试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Management of low responders is a challenge in the field of assisted reproduction. Several trials comparing frozen versus fresh embryo transfer have been published and are restricted mainly to high and normal responders. Current studies on the suitability of frozen embryo transfer in low responders are limited and yielded mixed results. OBJECTIVE: To investigate whether cryopreservation of all embryos and subsequent frozen embryo transfer produces better reproductive outcomes compared with fresh embryo transfer in low responders. EVIDENCE REVIEW: We searched PubMed, Embase, Cochrane Library, Web of Science Core Collection and Scopus databases from inception to December 2025. After de-duplication, titles and abstracts of 4,423 articles were screened, and 154 full-text articles were assessed for eligibility. One randomized controlled trial and 14 nonrandomized studies were included in the systematic review. Data extraction was performed for the primary outcome of live birth rate and secondary outcomes. FINDINGS: High certainty evidence from 1 randomized controlled trial showed that frozen embryo transfer resulted in a reduction in live birth (risk ratio [RR], 0.79; 95% confidence interval [CI], 0.65-0.94), clinical pregnancy (RR, 0.83; 95% CI, 0.71-0.97) and cumulative live birth rate (RR, 0.86; 95% CI, 0.75-0.99), whereas nonrandomized studies provided very uncertain evidence that there was no significant difference in the 2 groups including live birth rate (RR, 1.00; 95% CI, 0.65-1.55). A lower miscarriage rate favoring fresh embryo transfer was found in women fulfilling the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number criteria (RR, 1.31; 95% CI, 1.11-1.56). Consistent evidence indicated that frozen embryo transfer did not produce significant improvements in other reproductive outcomes. CONCLUSION AND RELEVANCE: Our results suggested that the "freeze-all" strategy did not produce better reproductive outcomes compared with fresh embryo transfer in low responders. Reproductive outcomes may be improved by performing fresh embryo transfer, which could be explained by a more physiological endometrium or better embryo quality without injury caused by cryopreservation. These findings should be further explored in randomized trials. TRIAL REGISTRATION: The review protocol was registered at PROSPERO (trial registration number: CRD420251138047, URL: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251138047). Date of registration: 9 September 2025.
引用
- Sun Y, Sun X, Gemzell-Danielsson K, et al. Frozen versus fresh embryo transfer in low responders: a systematic review. Fertil Steril. 2026. PMID: 41856346. doi:10.1016/j.fertnstert.2026.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。